NCT00543712 2022-12-13
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Genentech, Inc.
Phase 2 Terminated
Genentech, Inc.
Ludwig Institute for Cancer Research
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)